Articles

“You’re supposed to celebrate your survival and get on with your life, but that’s also when the bills come due. So it becomes that much harder to ask for help,” said Ms Watson.

Read More ›

At the 2018 Cancer Survivorship Symposium, Erin Van Blarigan, ScD, advises that cancer survivors who follow the general recommendations for diet and exercise experience longer survival times and improved quality of life. Read More ›

Ovarian cancer affects the glands found in women that produce eggs, known as ova, for reproduction. The American Cancer Society estimates that 22,240 women will be diagnosed with new cases of ovarian cancer in 2018, and 14,070 women will die from the disease during the same year. Read More ›

A claims analysis of elderly patients with pancreatic cancer has shown that those receiving early palliative care consultations had lower healthcare utilization, including emergency department-related costs, than patients who received late palliative care. Read More ›

In 2010, FORCE: Facing Our Risk of Cancer Empowered successfully spearheaded passage of a congressional resolution declaring the first-ever National Hereditary Breast and Ovarian Cancer week.

Read More ›

The September issue of The Oncology Nurse-APN/PA (TON) is filled with important news and updates for oncology nurses. Read More ›

• Venclexta Indicated for CLL or SLL, Alone or in Combination with Rituxan
• Keytruda Receives 2 New Indications: Metastatic Cervical Cancer and Relapsed Mediastinal Large B-Cell Lymphoma
• Bevacizumab Plus Chemotherapy Approved for Several Types of Ovarian Cancer

Read More ›

The novel drug sacituzumab govitecan is showing significant promise in HER2-negative breast cancers. “The benefit was durable, with an estimated medical duration of response of 7.4 months,” reported Aditya Bardia, MD, MPH. Read More ›

“Our study shows that medical marijuana is a salient topic in cancer care today, and the majority of oncologists think it may have utility for certain patients….however, data on medical marijuana use is less so,” said Ilana M. Braun, MD. Read More ›

Chicago, IL—In the United States, black men are twice as likely to die from prostate cancer as white men, and they are often diagnosed at a younger age and at later stages of the disease. Read More ›